{"originalText": "，缘于4个月前因食管胃交界腺癌于我院行（2015.10.19）正中开腹根治性全胃切除+食管-空肠ROUX-EN-Y吻合+空肠造瘘+脾切除术，术后病理（201537413），：(全胃)，：食管-胃交界处溃疡型混合型腺神经内分泌癌【腺癌为管状腺癌II-III级，神经内分泌肿瘤为G3型（神经内分泌癌）】，浸润脉管及神经组织，脉管内见癌栓，侵出浆膜层。手术标本下切端、上切端，及另送(最下切端)均未见癌浸润。找到贲门周淋巴结1/4个，小弯侧淋巴结1/11个，大弯侧淋巴结0/6个，幽门上淋巴结0/2个。脾脏组织。，免疫组化染色结果：KI67（30%阳性），P53（++），MLH1（++），MSH-6（+++），CGA（+++），CD56（++），SY（++）。（MM2051901）该病例未检测到KRAS基因12、13号密码子热点突变。（MM20151902）该病例未检测到BRAF基因V600E突变。术后恢复良好，目前进食半流质膳食，无不适。分别于2015.11.25、2015.12.25、2016.01.21日行3周期化疗，“顺铂40MG静滴D1-3+紫杉醇180MG静滴D2”方案，今为求术后第4周期化疗再诊我院，门诊拟食管胃交界腺癌术后化疗收住我科。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 15}, {"label_type": "手术", "overlap": 0, "start_pos": 31, "end_pos": 69}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 93, "end_pos": 149}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 466, "label_type": "药物", "overlap": 0, "start_pos": 464}, {"end_pos": 480, "label_type": "药物", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 512, "end_pos": 521}]}
